Literature DB >> 24560494

The interplay of human chorionic gonadotropin (hCG) with basic fibroblast growth factor and adipokines on angiogenesis in vitro.

A Połeć1, P Fedorcsák2, A Eskild3, T G Tanbo4.   

Abstract

INTRODUCTION: Human chorionic gonadotropin (hCG) is suggested to regulate placental angiogenesis, however, its role is incompletely understood. hCG may directly stimulate angiogenesis or influence the effect of other angiogenic factors. We examined the effect of hCG and the interplay of hCG with basic fibroblast growth factor (bFGF) and with various adipokines on proliferation of vascular endothelial cells in vitro.
METHODS: Human umbilical vein endothelial cells (HUVEC) were incubated for 2 days with combinations of hCG, bFGF, leptin, resistin, adiponectin, IL6 and TNFα. Incorporation of radiolabelled thymidine was used to assess cell proliferation. Immunofluorescence and flow cytometry were used to examine activation of p44/42 mitogen-activated kinase (MAPK).
RESULTS: hCG induced proliferation of HUVEC alone and in combination with bFGF. Cells exposed to both hCG and bFGF displayed increased activation of p44/42 MAPK as compared to hCG or bFGF alone. Increased HUVEC proliferation was observed in the presence of increasing concentrations of leptin, resistin, adiponectin, and IL6, whereas HUVEC proliferation decreased in the presence of TNFα. hCG in combination with leptin, resistin, adiponectin or IL6 stimulated HUVEC proliferation beyond the effect of hCG alone. DISCUSSION: An interplay of hCG with adipose tissue-derived factors with angiogenic properties is plausible. Thus, maternal obesity may affect placental angiogenesis in pregnancy.
CONCLUSIONS: hCG may directly stimulate angiogenesis. Also, hCG may indirectly stimulate angiogenesis through interplay with bFGF and adipokines.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adipokines; Angiogenesis; Basic fibroblast growth factor; Cell signaling; Human chorionic gonadotropin; Placenta

Mesh:

Substances:

Year:  2014        PMID: 24560494     DOI: 10.1016/j.placenta.2014.02.002

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  6 in total

1.  Maternal concentrations of human chorionic gonadotropin (hCG) and risk for cerebral palsy (CP) in the child. A case control study.

Authors:  Anne Eskild; Lars Monkerud; Anne Marie Jukic; Bjørn Olav Åsvold; Kari Kveim Lie
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2018-07-04       Impact factor: 2.435

2.  Arterial Hypertension Is Characterized by Imbalance of Pro-Angiogenic versus Anti-Angiogenic Factors.

Authors:  Natalia Marek-Trzonkowska; Anna Kwieczyńska; Magdalena Reiwer-Gostomska; Tomasz Koliński; Andrzej Molisz; Janusz Siebert
Journal:  PLoS One       Date:  2015-05-07       Impact factor: 3.240

3.  Identification of anti-tumor components from toad venom.

Authors:  Fei Gao; Xiangjun Wang; Zhao Li; Aicun Zhou; Evelyn Tiffany-Castiglioni; Lijun Xie; Yongchang Qian
Journal:  Oncol Lett       Date:  2017-05-12       Impact factor: 2.967

4.  Correlation of metabolic characteristics with maternal, fetal and placental asprosin in human pregnancy.

Authors:  Thorben Hoffmann; Yousef Ashraf Tawfik Morcos; Ruth Janoschek; Eva-Maria Turnwald; Antje Gerken; Annette Müller; Gerhard Sengle; Jörg Dötsch; Sarah Appel; Eva Hucklenbruch-Rother
Journal:  Endocr Connect       Date:  2022-03-14       Impact factor: 3.335

Review 5.  Modulation of endothelial cell migration by ER stress and insulin resistance: a role during maternal obesity?

Authors:  Pablo J Sáez; Roberto Villalobos-Labra; Francisco Westermeier; Luis Sobrevia; Marcelo Farías-Jofré
Journal:  Front Pharmacol       Date:  2014-08-19       Impact factor: 5.810

6.  Does the Biological Response to Fetal Hypoxia Involve Angiogenesis, Placental Enlargement and Preeclampsia?

Authors:  Anne Eskild; Ellen Marie Strøm-Roum; Camilla Haavaldsen
Journal:  Paediatr Perinat Epidemiol       Date:  2016-05       Impact factor: 3.980

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.